Show Notes
Getting into oncology requires a lot of education and training. How does one deal with the success and stress of such a journey? In Part Two of this ASCO Education Podcast, moderator Dr. Aakash Desai – fellow at the Mayo Clinic along with guests Dr. Madison Conces – fellow at Cleveland Clinic, and Hematology/Oncology fellowship program directors Dr. Lori J. Rosenstein (Gundersen Health System) and Dr. Deepa Rangachari (Beth Israel Deaconess Medical Center) explore the past, present, and future of Oncology Training. They discuss the transition from training to clinical practice (1:02), how to stay current with new treatments and guidelines (6:39) and what oncology training should look like in the future (12:12). Resources: ASCO Education Podcast: Cancer Topics - Burnout in Oncology: Trainee Perspective ASCO Education Podcast: Cancer Topics – Career Paths in Oncology (Part 1) ASCO Education Podcast: Cancer Topics – Career Paths in Oncology (Part 2) If you liked this episode, please subscribe. Learn more at education.asco.org, or email us at [email protected]. TRANSCRIPT Dr. Deepa Rangachari: I think really this idea of what I call work-life negotiation, is present very much during training, and one continues to be very present in your ongoing clinical practice. Aakash Desai: Hello, everyone, this is Dr. Aakash Desai, I am currently a Hematology and Oncology fellow at Mayo Clinic, in Rochester, and this is part two of our discussion on the past, present, and future of Oncology training. My guests are, Dr. Madison Conces, Hematology/Oncology fellow at Cleveland Clinic, Dr. Lori Rosenstein, Hematology, and Oncology Fellowship Program Director, at Gundersen Health System, and Dr. Deepa Rangachari, Fellowship Program Director, at Fellowship Program Director, at Beth Israel Deaconess Medical Center. In part one, we gave our insight into what motivated us to get into Oncology, along with spotlighting the rewards and stresses of going through fellowship. Today, we're going to look at what the future of Oncology should look like. But first, I and my guests will explore the challenges of transitioning from training to clinical practice in Oncology. Lori, gives us her answer. Dr. Lori Rosenstein: You know, I think part of it is, you are in that final stage, this is the rest of your life. So, I think a lot of my fellows feel like when they're leaving fellowship, they have to find the perfect job, because it's where they're going to be for the rest of their life, and I think everybody who is out in practice knows that it's very unlikely you stay in the first job out of fellowship. And so, having less stress on yourself, of finding that perfect experience, I think, finding an experience that fits with your goals and aspirations, and what you see your life being like, is good enough. And then if you go there, and it turns out it's not a great situation for you, feeling free to go somewhere else, that's a different paradigm than I think fellows expect. They put so much stress on themselves. We're all type-A people, right? And you just want to make the right choice. I've now had a couple of jobs. Each of them was the right choice for me at the time, and each of them taught me really important lessons that I have carried on to my next role. When I started my first job out of fellowship, I had no idea medical education was going to be a huge part of my life and career. I like to teach - that was what I knew about myself, but as I got more involved in medical education as a career, as a research opportunity, as probably the most important part of what I do in work, it changed where I was going to go. It changed what I ended up doing. You know, I ended up as a program director, and when I talked to my fellows and I say, you know, my job is research and taking care of patients, and teaching, and then medical education. To me, medical education is at the top, and that would not have been what I said as I left fellowship. So, having
More from ASCO Education
Dr. Kimmie Ng sits down with host Dr. Hope Rugo to discuss the steady rise in early-onset cancer globally, as detailed in the co-authored ASCO Educational Book article, Understanding Contemporary Challenges in the Care of Patients With Early-Onset Cancer: Epidemiologic Trends, Patient Well-Being, Oncofertility, and Cancer Survivorship. LINK TO FULL TRANSCRIPT
Dr. Christopher Booth joins guest host Dr. Gerald Hsu to discuss his ASCO Educational Book article, "Innovation, Evidence, Compassion, and Hope: Delivering Outcomes That Matter," exploring how modern trial metrics and regulatory pathways frequently prioritize surrogate endpoints over meaningful survival and quality-of-life gains. Together, they discuss actionable strategies for clinicians and policymakers to re-center cancer care on shared decision-making, patient priorities, and global access. LINK TO FULL TRANSCRIPT
Guest host Dr. Gerald Hsu and Dr. Martin Dreyling discuss the latest clinical data in mantle cell lymphoma, as well as risk stratification methods and the future role of chemo-free regimens and immunotherapy in MCL. LINK TO FULL TRANSCRIPT
Dr. Pedro Barata and Dr. Giuseppe Curigliano discuss the rapid paradigm shift of antibody-drug conjugates into frontline advanced and curative-intent perioperative settings and the clinical challenges of optimal sequencing, target selection, and cross-resistance. LINK TO FULL TRANSCRIPT
Dr. Pedro Barata and Dr. Bridget Keenan discuss the innovative bioengineering allowing clinicians to target historically "immune-cold" tumors, the logistical evolution of bringing bispecific therapies safely into outpatient community clinics, and the complex future of predictive biomarkers and resistance mechanisms. LINK TO FULL TRANSCRIPT